论文部分内容阅读
目的研究并探讨曲美他嗪联合阿托伐他汀治疗冠心病的临床效果。方法 100例冠心病患者,采用随机数字表法分为对照组和观察组,每组50例。对照组单独给予曲美他嗪治疗,观察组给予曲美他嗪联合阿托伐他汀治疗。对比两组疗效。结果观察组患者治疗显著29例、有效16例、无效5例,总有效率为90.0%;对照组患者治疗显著21例、有效16例、无效13例,总有效率为74.0%;观察组患者总有效率高于对照组,差异具有统计学意义(χ~2=4.336,P<0.05)。结论曲美他嗪联合阿托伐他汀治疗冠心病相对于曲美他嗪单独治疗具有明显的优越性,值得临床推广。
Objective To study and discuss the clinical effect of trimetazidine combined with atorvastatin on coronary heart disease. Methods One hundred patients with coronary heart disease were randomly divided into control group and observation group with 50 cases in each group. The control group was given trimetazidine alone and the observation group was given trimetazidine combined with atorvastatin. Compare two groups curative effect. Results In observation group, there were 29 cases in treatment group, 16 cases in effective group and 5 cases in ineffective group. The total effective rate was 90.0%. In the control group, 21 cases were significantly treated, 16 cases were effective and 13 cases were ineffective. The total effective rate was 74.0% The total effective rate was higher than the control group, the difference was statistically significant (χ ~ 2 = 4.336, P <0.05). Conclusion Trimetazidine combined with atorvastatin has obvious advantages over trimetazidine alone in the treatment of coronary heart disease, which is worthy of clinical promotion.